I do wonder what the FDA really knows about our tr
Post# of 148288
(Total Views: 813)
Posted On: 06/26/2020 12:18:50 PM
I do wonder what the FDA really knows about our trials, and whether recent comments by the White House actually refer to leronliomab.
P3 S/C
Clinical Study: https://clinicaltrials.gov/ct2/show/NCT04347239
Proactive Video: https://www.youtube.com/watch?v=K3Gn9gjVvcY
During the June 15 Proactive video, we were told that the last patient of the 51 patient interim block had been injected before the beginning of June. Assuming that injection took place on May 31, that puts us at June 28 (Sunday).
What I don't know is if they unblind that 51 patient interim block all at the same time (on June 28), or if they have been progressively unblinding and processing that data as each patient has reached Day 28. Remember, there are a number of secondary endpoints beyond just mortality at Day 28.
P2 M/M
Clinical Study: https://clinicaltrials.gov/ct2/show/NCT04343651
Proactive Video: https://www.youtube.com/watch?v=K3Gn9gjVvcY
During the same Proactive video, we were told the trial would be most likely locked on June 17 and that the results of the trial would be unblinded 14 days later on July 1 (Wednesday). Again, I don't know is if they are going to unblind all of that patient data starting on July 1, or if they have been progressively processing that data as each patient has reached Day 14.
Everyone knows these facts, but this was my long-winded way of wondering aloud what the FDA could actually know, and whether they would have shared it with the White House.
I also don't know if there are any other therapeutics reporting top line results that the White House could be referring to? It would not surprise me to learn that the Fauci distortion machine is still trying to find ways to thrust remdesivir on an unsuspecting public. And to that end, I have found the following remdesivir combo trials, but I don't know the timing of their endpoints
remdesivir + baricitinib
Clinical Study: https://clinicaltrials.gov/ct2/show/NCT044015...amp;draw=2
remdesivir, lopinavir/ritonavir, interferon Beta-1A, hydroxychloroquine
Clinical Study: https://clinicaltrials.gov/ct2/show/NCT04315948
remdesivir + tocilizumab
Clinical Study: https://www.clinicaltrials.gov/ct2/show/NCT04409262
Facts, corrections and opinions on everything listed above are welcomed.
P3 S/C
Clinical Study: https://clinicaltrials.gov/ct2/show/NCT04347239
Proactive Video: https://www.youtube.com/watch?v=K3Gn9gjVvcY
During the June 15 Proactive video, we were told that the last patient of the 51 patient interim block had been injected before the beginning of June. Assuming that injection took place on May 31, that puts us at June 28 (Sunday).
What I don't know is if they unblind that 51 patient interim block all at the same time (on June 28), or if they have been progressively unblinding and processing that data as each patient has reached Day 28. Remember, there are a number of secondary endpoints beyond just mortality at Day 28.
P2 M/M
Clinical Study: https://clinicaltrials.gov/ct2/show/NCT04343651
Proactive Video: https://www.youtube.com/watch?v=K3Gn9gjVvcY
During the same Proactive video, we were told the trial would be most likely locked on June 17 and that the results of the trial would be unblinded 14 days later on July 1 (Wednesday). Again, I don't know is if they are going to unblind all of that patient data starting on July 1, or if they have been progressively processing that data as each patient has reached Day 14.
Everyone knows these facts, but this was my long-winded way of wondering aloud what the FDA could actually know, and whether they would have shared it with the White House.
I also don't know if there are any other therapeutics reporting top line results that the White House could be referring to? It would not surprise me to learn that the Fauci distortion machine is still trying to find ways to thrust remdesivir on an unsuspecting public. And to that end, I have found the following remdesivir combo trials, but I don't know the timing of their endpoints
remdesivir + baricitinib
Clinical Study: https://clinicaltrials.gov/ct2/show/NCT044015...amp;draw=2
remdesivir, lopinavir/ritonavir, interferon Beta-1A, hydroxychloroquine
Clinical Study: https://clinicaltrials.gov/ct2/show/NCT04315948
remdesivir + tocilizumab
Clinical Study: https://www.clinicaltrials.gov/ct2/show/NCT04409262
Facts, corrections and opinions on everything listed above are welcomed.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼